Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Protocol-based empirical 4-week oral voriconazole for peritoneal dialysis-related fungal peritonitis
TCTR20240402002Phase 3Not yet recruiting
- Sponsor
- Faculty of Medicine, Chulalongkorn University
- Start
- May 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of voriconazole in peritonitis, sponsored by Faculty of Medicine, Chulalongkorn University. Planned start May 2024; status: not yet recruiting.
02
Drugs
voriconazole
03
Conditions
peritonitis
Beyond the preview
Go deeper on TCTR20240402002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240402002.